Galveston County, Texas, funds by Health and Human Services, Department of
Listing $23,461,927.65 in stimulus funds from Health and Human Services, Department of for Galveston
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $1,847,316 |
Trans-NIH Recovery Act Research Support Small animal models of infectious disease play a central role in research programs aimed at identifying leads and approaches that could be exploited to devise improved diagnostics, pre-treatments and therapies against bioterrorism agents. However, the fur
This spending item is part of a $1,895,757 allocation.
See details
|
National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $1,530,000 | Trans-NIH Recovery Act Research Support Addiction is a chronic, relapsing brain disorder. While treatment can work to decrease morbidity and mortality associated with this disorder, a larger armamentarium of effective and accessible treatments for addiction is needed to significantly reduce the | National Institutes of Health | 9/21/2009 |
| GALVESTON COMMUNITY ACTION COUNCIL, INC | $1,318,657 |
ARRA - Community Services Block Grant The CSBG ARRA award is Recovery Act funding for the Community Services Block Grant. The purpose of the program is to provide supplemental funds for job preservation, infrastructure investment, energy efficiency and science, assistance to the unemployed a
This spending item is part of a $48,148,071 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $988,970 |
Trans-NIH Recovery Act Research Support Flaviviruses populate the NIAID's Category A, B, and C lists of viruses. Vaccines are urgently needed for multiple flavivirus diseases, notably dengue and West Nile encephalitis. To develop more effective vaccines a comprehensive understanding of how flav
This spending item is part of a $1,212,096 allocation.
See details
|
National Institutes of Health | 7/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $861,979 |
Trans-NIH Recovery Act Research Support Chikungunya virus (CHIKV) is an emerging, mosquito-borne alphavirus and potential biological weapon that has caused debilitating, chronic arthralgia in at least 2 million persons in Asia and Africa since 2005. CHIKV was recently placed on the National In
This spending item is part of a $1,933,570 allocation.
See details
|
National Institutes of Health | 7/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $841,500 | Trans-NIH Recovery Act Research Support Alzheimer's Disease (AD) is an age-associated dementia for which there is currently no cure. AD is characterized by memory deficits, loss of CNS neurons, and eventually death. One of the prominent events in AD is the central nervous system (CNS) presence | National Institutes of Health | 6/05/2009 |
| GALVESTON COUNTY COORDINATED C | $812,730 | ARRA Health Center Integrated Services Development Initiative[g1] CIP funding is being utilized to replace an existing Electronic Practice Management System (EPM), and in addition, provide a fully integrated new Electronic Health Record (EHR) and Electronic Dental Record (EDR) system that meets HRSA A requirements, includ... Show more | Health Resources and Services Administration | 6/25/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $755,000 | Trans-NIH Recovery Act Research Support Uveitis, an ocular inflammatory disease of unknown etiology, is a major complication during autoimmune disorders and infections and is associated with severe visual impairment. Uveitis may result from direct involvement of the uveal tract or indirect infl | National Institutes of Health | 7/15/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $656,488 | Trans-NIH Recovery Act Research Support Starting in the 1990's, some physicians began to devote all of their time to the care of hospitalized patients. They are referred to as hospitalists. Our preliminary data suggest a rapid growth in the number of hospitalized older patients cared for nation | National Institutes of Health | 9/02/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $648,146 |
Trans-NIH Recovery Act Research Support Ebola, Marburg, and Lassa viruses are enigmatic emerging pathogens that cause severe Hemorrhagic Fever (HF) in humans and nonhuman primates. Outbreaks occur regularly in the case of Lassa and sporadically in the case of the flioviruses in parts of Africa
This spending item is part of a $908,442 allocation.
See details
|
National Institutes of Health | 9/24/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $598,443 | Trans-NIH Recovery Act Research Support In the past funding period we confirmed our major hypothesis that progastrin peptides (PG) exert proliferative/anti-apoptotic/co-carcinogenic effects on intestinal/colonic epithelial cell lines, in vitro and in vivo, and increase the risk of colon carcino | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $598,040 |
Trans-NIH Recovery Act Research Support Cyclooxygenase (COX) inhibitors lower the risk of colorectal cancer (CRC) and inhibit tumor growth in animal and cell culture models. However, their efficacy in treating existing CRC remains controversial. Previous research in our laboratory has demonstra
This spending item is part of a $619,988 allocation.
See details
|
National Institutes of Health | 5/13/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $597,504 | NHSC Student/Resident Experiences and Rotations in Community Health (SEARCH) - East Texas Area Health Education Center | Health Resources and Services Administration | 9/29/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $555,980 |
Trans-NIH Recovery Act Research Support The Gulf Coast Transdisciplinary Research Recovery Center for Community Health brings together outstanding academic and public health institutions and centers as a Consortium. The Consortium will coordinate new research studies and projects with existing
This spending item is part of a $4,000,000 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $549,708 | Trans-NIH Recovery Act Research Support A new paradigm to treat gut bacteria-associated sepsis is urgent for persons who have radiation-associated damage in gastrointestinal system caused by terrorist acts or accidental exposure. Antibiotics are effective against these infections, however; anti | National Institutes of Health | 3/25/2010 |
| GALVESTON COUNTY COORDINATED C | $464,038 | ARRA Health Center Integrated Services Development Initiative[g1] Grant Name: ARRA ? Increase Services to Health Centers. Purpose: To increase the capacity to serve the uninsured and underinsured population of Galveston County. The Galveston County Coordinated Community Clinics (4C?s) has been proroviding ambulatory pr... Show more | Health Resources and Services Administration | 3/27/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $443,669 | Trans-NIH Recovery Act Research Support Award Description* DESCRIPTION (provided by applicant): Zinc is now believed to be an intracellular second messenger. It is hepatoprotective against various toxins and counteracts the oxidative stress elicited by compounds that have been linked to liver d | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $435,992 | Trans-NIH Recovery Act Research Support Recent advances in biology and medicine continuously bring new opportunities to basic, translational, and clinical research. New instrumentation and computational tools such as mass spectrometry are drivers behind these advances by delivering novel approa | National Institutes of Health | 4/15/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $415,250 | Trans-NIH Recovery Act Research Support Francisella tularensis is a gram-negative bacterium and one of the top-priority agents ('Class A') most likely to pose a potential risk to national security. Although much has been learned from a mouse model using an attenuated strain of Francisella, Fran | National Institutes of Health | 5/19/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $415,250 | Trans-NIH Recovery Act Research Support Although genetic predisposition and environmental factors such as exposure to genotoxic agents play critical etiological roles in many cancers, no gene yet has been identified as being directly responsible for the development of sporadic lung cell carcino | National Institutes of Health | 5/18/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $409,756 | Trans-NIH Recovery Act Research Support This application requests five years of funding for the UTMB training program in Health of Older Minorities. This program was originally funded in 1999 and now supports three pre-doctoral and three postdoctoral positions. In this application we are reques | National Institutes of Health | 5/19/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $395,866 | Trans-NIH Recovery Act Research Support This project requests continued support for the National Institute of Environmental Health Sciences (NIEHS) Center at the University of Texas Medical Branch (UTMB). The mission of this Center is to integrate, coordinate and foster interactions and collabo | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $375,613 | Trans-NIH Recovery Act Research Support Despite extensive research, the etiology of Crohn's inflammatory bowel disease remains unknown with possible suggestions attributed to genetic susceptibility, infectious agents, immune dysfunction, and various environmental agents. A number of clinical st | National Institutes of Health | 5/26/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $375,255 | Trans-NIH Recovery Act Research Support Toxins, pathogenic infection (viral and bacterial), and physical injury to the liver results in a loss of hepatic tis- ue, triggering a regenerative response to restore liver cell mass. Dysregulation in the repair process can lead o liver failure or liver | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $371,532 |
Trans-NIH Recovery Act Research Support Inflammatory Bowel Diseases (IBDs) reflect dysregulated immune responses to gut flora where CD4+ T cells cause tissue damage. Colonic subepithelial myfibroblasts (CMFs), a cell population located directly subadjacent to the epithelium, interact with and a
This spending item is part of a $394,229 allocation.
See details
|
National Institutes of Health | 8/02/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $365,418 | Trans-NIH Recovery Act Research Support Helicobacter pylori (Hp) infects the gastric mucosa of >50% of the world's population. Infection with this gram negative bacterium results in significant gastroduodenal diseases that include chronic gastritis, ulcers and cancer. Prevalence rates of Hp inf | National Institutes of Health | 5/15/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $344,250 | Trans-NIH Recovery Act Research Support The overall goal of this project is to develop more effective therapeutic regimens for the treatment of colorectal cancer. These regimens will target not only malignant epithelial cells of the tumor, but also the cancer stem cells responsible for tumor r | National Institutes of Health | 8/30/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $312,428 | Trans-NIH Recovery Act Research Support The overall goal of this project is to develop more effective therapeutic regimens for the treatment of colorectal cancer. These regimens will target not only malignant epithelial cells of the tumor, but also the cancer stem cells responsible for tumor re | National Institutes of Health | 3/25/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $292,657 |
Trans-NIH Recovery Act Research Support There is an urgent need to develop more effective vaccines and antibiotic regimens against many of the Select Agent bacteria that cause lethal infection in humans. This is particularly true for the candidate bioterrorism agents, Burkholderia. pseudomallei
This spending item is part of a $1,006,212 allocation.
See details
|
National Institutes of Health | 7/05/2011 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $272,525 | Trans-NIH Recovery Act Research Support Evaluation of safety and efficacy of microbicides requires an assessment of potential injury caused by micobicides in the epithelium of cervicovaginal tract and rectum. The development of imaging technology and protocols that can be used for endoscopic, r | National Institutes of Health | 6/09/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $263,061 |
Trans-NIH Recovery Act Research Support The leishmaniasis have significant global impact; 350 million people on 5 continents are at risk and an estimated 10?50 million people in endemic tropical and subtropical regions are affected. Hundreds of thousands of people have died in recent years in e
This spending item is part of a $499,826 allocation.
See details
|
National Institutes of Health | 2/04/2011 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $256,981 |
Trans-NIH Recovery Act Research Support Influenza viruses are among the most frequent causes of severe respiratory illness, and new influenza viruses continue to cause re-emerging and newly emerging disease that resists established vaccines. Since existing therapy is unsatisfactory, we develope
This spending item is part of a $1,976,256 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $253,515 | Trans-NIH Recovery Act Research Support This award will provide partial support for the acquisition of a Biacore T100 surface plasmon resonance system at the University of Texas Medical Branch (UTMB) in Galveston. Molecular recognition is one of the most important problems in biology and medici | National Institutes of Health | 4/27/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $251,781 | Trans-NIH Recovery Act Research Support HIV infection of primary human cells typically requires interaction of Env gp120 with both the primary receptor CD4 and a chemokine receptor, either CCR5 or CXCR4, followed by Env gp41-induced fusion. Involvement of other factors and processes are likely, | National Institutes of Health | 7/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $243,004 | Trans-NIH Recovery Act Research Support The reported association between an unfavorable fetal environment and adult diseases may be confounded by a genetic predisposition toward specific diseases (eg, vascular diseases) as the maternal genes that are transmitted o the fetus may also set the ute | National Institutes of Health | 7/15/2009 |
| GALVESTON COMMUNITY ACTION COUNCIL, INC | $201,022 | ARRA - Head Start Award Title: American Recovery and Reinvestment Act Discretionary Head Start Grant. This award provides for ARRA Cost of Living Adjustment (COLA), and Quality Improvement (QI) Funding consistent with the provisions of Section 640(a)(5) of the Head Start A | Administration for Children and Families | 6/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $191,432 | Trans-NIH Recovery Act Research Support Individual cells display stochastic variability in their responses to activating stimuli. In cells taking part in the innate immune response this variability seems very important. Cells react differently to the same stimulus, e.g. some proliferate some mo | National Institutes of Health | 4/09/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $191,250 |
Trans-NIH Recovery Act Research Support Hepatitis C virus (HCV) infection persists for years in most patients and leads to chronic liver disease despite robust immune responses. Although there are no clearly established in vitro correlates of protective immunity, multiple lines of evidence sugg
This spending item is part of a $406,250 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $174,781 | Trans-NIH Recovery Act Research Support The aim of these studies is to understand the precise signaling mechanisms which regulate calcium release from inositol 1,4,5- trisphosphate receptor channels during apoptosis, with the ultimate goal of identifying novel targets for therapeutic interventi | National Institutes of Health | 3/10/2010 |
| HITCHCOCK INDEPENDENT SCHOOL DISTRICT | $173,485 | ARRA - Head Start ARRA Head Start from OA/OGM/Region VI - The purchase of a school bus enable the Head Start program to transport more students to and from school to better serve the needs of our families. An intercom system was installed in each classroom and the gym to | Administration for Children and Families | 7/01/2009 |
| HITCHCOCK INDEPENDENT SCHOOL DISTRICT | $173,485 | ARRA - Head Start Early Childhood COLA and Quality Improvement ARRA | Administration for Children and Families | 7/01/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $153,000 | Trans-NIH Recovery Act Research Support The University of Texas Medical Branch (UTMB) has the capability to participate actively as a member of the Obstetric-Fetal Pharmacology Research Units (OPRU) Network. Gary Hankins, MD, as PI, is responsible for the proposed clinical trial on the use of h | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $153,000 | Trans-NIH Recovery Act Research Support Glioblastoma (GB) is the most common type of brain tumor and is usually rapidly fatal. Clinical trials indicate that treatment with temozolomide (TMZ) coupled with chemotherapy is beneficial to patients. Unfortunately, only a small number of patients resp | National Institutes of Health | 6/03/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $151,000 | Trans-NIH Recovery Act Research Support Burkholderia (B.) mallei is a highly evolved Gram-negative bacterium that primarily infects solipeds but it is transmissible to humans by ingestion, cutaneous or aerosol exposures. Concern over this bacterium and the very closely related species B. pseudo | National Institutes of Health | 7/15/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $133,875 |
Trans-NIH Recovery Act Research Support Chikungunya virus (CHIKV), an Alphavirus in the family Togaviridae, causes sporadic, but explosive epidemics of mosquito-borne disease in humans. The symptoms are almost indistinguishable from dengue fever, with acute febrile illness and associated crippl
This spending item is part of a $429,298 allocation.
See details
|
National Institutes of Health | 2/03/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $125,460 | Trans-NIH Recovery Act Research Support The goal of the proposed research is to examine the prevalence of obesity and the relationship between obesity, muscle strength, and disability among older Mexican Americans in the United States (U.S.) and elders from Latin America and the Caribbean. Very | National Institutes of Health | 5/18/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $108,000 | Trans-NIH Recovery Act Research Support The goal of this project for an Established Investigator Award in Cancer Prevention, Control, Behavioral, and Population Sciences is to allow Dr. Goodwin to reduce his administrative responsibilities so that he can devote 70% time to mentoring junior facu | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $108,000 | Trans-NIH Recovery Act Research Support As global commerce and immigration have increased, there is an acute need for training programs focused on global health. Galveston is a natural site for such as training program. Galveston is a major port and international trade was the main impetus for | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $107,957 | Trans-NIH Recovery Act Research Support The incidence of Hepatitis C Virus (HCV) infection in the general population is growing significantly which is of great concern. The progression of the viral infection as well as treatment modality critically depends on the patient's stage of fibrosis. Th | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $100,874 | Trans-NIH Recovery Act Research Support Immunoglobulin A (IgA) has been shown to be critical in mucosal immune defense. Intestinal IgA can be produced by both T cell-dependent and T cell-independent pathways, however, the relative importance of each and how they are regulated are still largely | National Institutes of Health | 9/29/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $99,985 | Trans-NIH Recovery Act Research Support The long term goal of this research project is to understand the role of ehrlichial glycoproteins in protective immunity to Ehrlichia chaffeensis. The proposal aims to further the limited understanding of ehrlichial glycoproteins and their role in immunit | National Institutes of Health | 9/07/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $98,595 |
Trans-NIH Recovery Act Research Support ARRA - Adducts as Quantitative Markers of Butadiene Mutagenesis - Administrative Supplement This administrative supplement will clearly accelerate the pace of research on mechanisms of BD carcinogenesis and mutagenesis. It has been designed to provide a c
This spending item is part of a $337,815 allocation.
See details
|
National Institutes of Health | 9/02/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $85,000 | Trans-NIH Recovery Act Research Support Request for a Multiplex analysis system to accelerate the tempo of investigations in diabetic complications. This system will allow for identification of a broader range of signaling pathways involved in the hyperglycemia and will also provide a novel di | National Institutes of Health | 12/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $76,817 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): For over half a century, androgen deprivation therapy (ADT) has been known to have beneficial effects on prostate cancer due to the testosterone dependence of prostate tumor cells, yet its optimal use still remains und
This spending item is part of a $482,660 allocation.
See details
|
National Institutes of Health | 7/13/2009 |
| NEUROBIOTEX | $71,559 |
Trans-NIH Recovery Act Research Support This is a competing renewal application. The overall thrust of the project is to develop novel fluorescent sensing and imaging technology for understanding the biology of zinc, with a view to developing novel and improved diagnostics and therapies for hum
This spending item is part of a $750,886 allocation.
See details
|
National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $71,356 | ARRA - Scholarships for Disadvantaged Students ARRA SCHOLARSHIPS FOR DISADVANTAGED STUDENTS | Health Resources and Services Administration | 9/03/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $68,454 | Trans-NIH Recovery Act Research Support Rickettsial diseases have been a scourge of humankind throughout history. Typhus epidemics due to louse- borne Rickettsia (R.) prowazekii have caused more deaths than all the wars combined and recent epidemiological evidence documents the reemergence of e | National Institutes of Health | 12/02/2011 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $59,421 | Trans-NIH Recovery Act Research Support Toxins, pathogenic infection (viral and bacterial), and physical injury to the liver results in a loss of hepatic tis- ue, triggering a regenerative response to restore liver cell mass. Dysregulation in the repair process can lead o liver failure or liver | National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $58,488 | Trans-NIH Recovery Act Research Support While strides have been made to reduce the lethality of septic shock, it is still a highly fatal condition that is on the rise. Immunomodulation may prove to be a viable treatment option for sepsis. Immunomodulation consists of the induction of an immunol | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $56,316 | Trans-NIH Recovery Act Research Support The objective of the proposed project is to evaluate the cellular immune response to Rift Valley fever virus (RVFV) wild-type (ZH501) and vaccine strain (MP-12) infections. There is very little published data pertaining to the effect of RVFV infection on | National Institutes of Health | 7/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $56,162 | Trans-NIH Recovery Act Research Support West Nile virus (WNV), a vector-borne pathogen, has resulted in annual outbreaks of viral encephalitis in North America since 1999. Severe neurological disease (encephalitis or death) has been observed in over 30% of the confirmed WNV cases with a higher | National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $53,298 | Trans-NIH Recovery Act Research Support p12CDK2AP1 Regulation of Normal and Neoplastic Growth. Administrative supplement to a parent K01 NCI Career Development Award to promote diversity. This supplement allows retention of one technical personnel, and this has significantly accelerated the pac | National Institutes of Health | 6/23/2011 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $38,020 | ARRA - Scholarships for Disadvantaged Students UTMB will use funds received as a tool to fund disadvantaged students in pursuing their education. Since this funding can be substantial, it is a tool we can use to recruit and retain these students, thus reducing their debt from expensive loan programsms.... Show more | Health Resources and Services Administration | 6/14/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $37,750 |
Trans-NIH Recovery Act Research Support The filoviruses, Ebola (EBOV) and Marburg (MARV), cause periodic hemorrhagic fever outbreaks in sub-Saharan Africa.-? Because of the high rates of mortality associated with these infections and high transmissibility of these viruses in the human populatio
This spending item is part of a $423,450 allocation.
See details
|
National Institutes of Health | 5/21/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $35,720 | Trans-NIH Recovery Act Research Support Alzheimer's Disease (AD) is an age-associated dementia for which there is currently no cure. AD is characterized by memory deficits, loss of CNS neurons, and eventually death. One of the prominent events in AD is the CNS presence of plaques that are mostl | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $30,537 |
Trans-NIH Recovery Act Research Support 'This project is aimed at developing rational strategies for the prevention and treatment of lung diseases such as BPD and ARDS in humans.. Hyperoxia is frequently used in the treatment of pulmonary insufficiency in premature infants. However, hyperox
This spending item is part of a $855,818 allocation.
See details
|
National Institutes of Health | 5/30/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $29,015 |
Trans-NIH Recovery Act Research Support For almost two decades, the W. M. Keck Center, which spans six biomedical institutions in the Greater Houston, Texas area, has trained pre- and postdoctoral fellows in biomedical informatics. Here we seek the renewal of one of our training programs (the N
This spending item is part of a $1,033,304 allocation.
See details
|
National Institutes of Health | 7/21/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $25,000 | ARRA ? Equipment to Enhance Training for Health Professionals To purchase equipment for a portable computer training lab to support our faculty development initiatives. The faculty development program is designed to help pediatric faculty develop a range of computer technology skills to enhance theirir effectiveness t... Show more | Health Resources and Services Administration | 9/04/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $20,101 | Trans-NIH Recovery Act Research Support The expression of Attaching and Effacing Escherichia coli (AEEC) virulence factors is a tightly regulated process, and, in some cases, the identification of these factors has been difficult because they are either repressed in vitro or the conditions of e | National Institutes of Health | 6/03/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $13,250 |
Trans-NIH Recovery Act Research Support This application requests continued support for the NIEHS Center at the University of Texas Medical Branch. The mission of this Center is to integrate, coordinate and foster interactions and collaborations among a group of established investigators pursui
This spending item is part of a $932,328 allocation.
See details
|
National Institutes of Health | 9/07/2009 |
| NEUROBIOTEX | $10,000 |
Trans-NIH Recovery Act Research Support This is a competing renewal application. The overall thrust of the project is to develop novel fluorescent sensing and imaging technology for understanding the biology of zinc, with a view to developing novel and improved diagnostics and therapies for hum
This spending item is part of a $750,886 allocation.
See details
|
National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $2,160 |
Trans-NIH Recovery Act Research Support Supplement to a primary grant, this initiative involves multiple institutions & addresses 3 G?bullet pointG? topics specified in the RFA: 1) CER skills for diverse health care researchers; 2) CER methodology skills development by economists, quality impro
This spending item is part of a $164,258 allocation.
See details
|
National Institutes of Health | 9/23/2010 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | $1 | Trans-NIH Recovery Act Research Support Award Description* DESCRIPTION (provided by applicant): Asymptomatic bacteriuria (ASB) is the isolation of a specified quantity of bacteria from a person without symptoms or signs referableto urinary infection. ASB is common in women and increases with ad | National Institutes of Health | 9/22/2009 |